Whalegun
Lobbying

Marius Pharmaceuticals's latest lobbying report covers Q4 2024, at $50K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Marius Pharmaceuticals

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Marius Pharmaceuticals lobbying by quarter
Marius Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$30K1
Q3 2023$10K1
Q4 2023$00
Q1 2024$00
Q2 2024$30K1
Q3 2024$40K2
Q4 2024$50K2
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$260K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Executive Office of the President (EOP)1 reports
  • Office of Management & Budget (OMB)1 reports

Firms it paid

Firm
Alb Solutions$220K7 quarters
Crossroads Strategies$40K2 quarters

Former officials lobbying for it

Former position
ADAM BUCKALEWCovered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS)Q4 2024

Lobbying reports

Filed by
25/01/21for Q4 2024Crossroads Strategies$30K
25/01/21for Q4 2024Alb Solutions$20K
24/10/20for Q3 2024Crossroads Strategies$10K
24/10/18for Q3 2024Alb Solutions$30K
24/10/15for Q3 2024Crossroads StrategiesUnder $5,000
24/07/21for Q2 2024Alb Solutions$30K
24/06/30for Q2 2024Alb SolutionsUnder $5,000
23/10/17for Q3 2023Alb Solutions$10K
23/07/19for Q2 2023Alb Solutions$30K
23/04/14for Q1 2023Alb Solutions$50K
23/01/15for Q4 2022Alb Solutions$50K